PT
Pheast Therapeutics, Inc.
SEC filingOther Technology · Redwood City, CA
Amount raised$24.6Msold at filing
Total offering$40M$15.4M still open
Investors in the raise7count reported to the SEC
FiledOct 16, 2025first sale Oct 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Irving WeissmanDirector
Roy MauteExecutive Officer, Director
Raphael RousseauExecutive Officer
Steven GillisDirector
Jacob VogelsteinDirector
Amira BarkalDirector
Thomas MartyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.